Claims
- 1. A method of preparing a molecularly imprinted polymer, the method comprising:
(a) dissolving a print molecule and monomer in an aqueous solution and dissolving a host polymer in an organic phase; (b) preparing an emulsion of the aqueous and the organic phases; (c) polymerizing the monomer to form a polymer composite with the host polymer along an interface between the organic phase and the aqueous phase; (d) separating the polymer composite from the emulsion; and (e) removing the print molecule from the composite, wherein the print molecule is a protein selected from trypsinogen, peroxidase, alkaline phosphatase, and glucose oxidase.
- 2. The method of claim 1, wherein the host polymer is polymethylmethacrylate.
- 3. The method of claim 1, wherein the monomer is pyrrole.
- 4. The method of claim 1, wherein the polymer composite comprises the host polymer and the polymerized monomer.
- 5. The method of claim 4, wherein the host polymer comprises between about 50% and about 60% of the polymer composite.
- 6. The method of claim 4, wherein the host polymer comprises between 60% and 80% of the polymer composite.
- 7. The method of claim 4, wherein the host polymer comprises more than 80% of the polymer composite.
- 8. The method of claim 1, wherein the host polymer provides structural support to the polymer composite.
- 9. The method of claim 1, wherein the host polymer provides a source of functional groups to contribute to print molecule recognition.
- 10. The polymer composite produced by the method of claim 1.
- 11. A method of using the polymer composite of claim 10, comprising:
packing the polymer composite into a column, wherein an affinity chromatography column is formed; and contacting the polymer composite with a mixture of proteins containing the print molecule.
- 12. The method of claim 11, further comprising:
eluting the target proteins from the polymer composite.
- 13. The method of claim 11, wherein the mixture is a bodily fluid.
- 14. The method of claim 11, wherein the mixture is selected from blood and urine.
- 15. The method of claim 12, wherein the step of eluting target proteins from the polymer composite further comprises:
washing the column with a first buffer solution to remove residual mixture contained within the column; and washing the column with a second solution to elute the target proteins.
- 16. A method of making an analytical device, comprising:
(a) dissolving a print molecule and a monomer in a first phase and dissolving a host polymer in a second phase, wherein the first and second phases are different phases and selected from an aqueous phase and an organic phase; (b) preparing an emulsion of the aqueous phase and the organic phase; (c) polymerizing the monomer to form a polymer composite with the host polymer along an interface between the first and second phases; (d) separating the polymer composite from the emulsion; and removing the print molecule from the composite. (e) forming the polymer composite on a substrate.
- 17. The method of claim 16, wherein the substrate is selected from silica particles, polystyrene particles, other chromatographic material, and combinations thereof.
- 18. The method of claim 16, wherein the substrate is selected from glass, fiberglass, polymeric surfaces, natural surfaces, metal surfaces, electrodes, and plastics.
- 19. The method of claim 16, wherein the substrate is magnetic.
Parent Case Info
[0001] This patent application is a continuation-in-part of U.S. patent application Ser. No. 09/642,796 filed Aug. 21, 2000.
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
09642796 |
Aug 2000 |
US |
Child |
10379386 |
Mar 2003 |
US |